| Autor: |
Underwood EC; Center for Global Health and Infectious Disease Research, University of South Florida, Tampa, FL 33612, USA., Vera IM; Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA., Allen D; Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA., Alvior J; Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA., O'Driscoll M; Tampa General Hospital, Tampa, FL 33606, USA., Silbert S; Tampa General Hospital, Tampa, FL 33606, USA., Kim K; Center for Global Health and Infectious Disease Research, University of South Florida, Tampa, FL 33612, USA.; Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.; Tampa General Hospital, Tampa, FL 33606, USA., Barr KL; Center for Global Health and Infectious Disease Research, University of South Florida, Tampa, FL 33612, USA. |
| Abstrakt: |
West Nile virus (WNV) is an arbovirus spread primarily by Culex mosquitoes, with humans being a dead-end host. WNV was introduced to Florida in 2001, with 467 confirmed cases since. It is estimated that 80 percent of cases are asymptomatic, with mild cases presenting as a non-specific flu-like illness. Currently, detection of WNV in humans occurs primarily in healthcare settings via RT-PCR or CSF IgM when patients present with severe manifestations of disease including fever, meningitis, encephalitis, or acute flaccid paralysis. Given the short window of detectable viremia and requirement for CSF sampling, most WNV infections never receive an official diagnosis. This study utilized enzyme-linked immunosorbent assay (ELISA) to detect WNV IgG antibodies in 250 patient serum and plasma samples collected at Tampa General Hospital during 2020 and 2021. Plaque reduction neutralization tests were used to confirm ELISA results. Out of the 250 patients included in this study, 18.8% of them were IgG positive, consistent with previous WNV exposure. There was no relationship between WNV exposure and age or sex. |
